Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 70771-1031

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 70771-1031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 01)

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 02)

This is the description of Diltiazem Hydrochloride Extended-Release Capsules. It contains 90 capsules of Diltiazem Hydrochloride, USP, with each capsule equivalent to 110.3 mg Diltiazem Hydrochloride. The recommended usual dosage is on the package insert. The capsules should be stored in a cool and dry place, and in a light-resistant and air-tight container. This drug should be kept out of reach of children. Cadila Healthcare Ltd manufactures it, and it is available only with a prescription.*

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 03)

Diltiazem Hydrochloride Extended-Release Capsules, USP 180mg is a medication intended for once-a-day use. 90 capsules are included in each bottle. The recommended dosage is listed in the package insert. It is important to store at temperatures between 20° to 25°C and to keep the capsules in a child-resistant container. The manufacturer is Caila Healthcare Ltd., located in Ahmedabad, India.*

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 04)

This is a prescription medication with the drug code "DC 70771-1032". Each capsule contains "Diltiazem Hydrochloride, USP" with a strength of 240mg. The medication is an extended-release type with dosage information available in the package insert. The medication should be stored between 20 to 25°C and should be kept in a light-resistant container with a child-resistant closure. The manufacturer is Cacila Healthcare L. and the medication should be kept away from children.*

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 05)

This text describes a medication named DI|tiazem, which is an extended-release capsule containing 300mg of Diltiazem Hydrochloride. It is advised to store this medication at room temperature, away from high humidity, in a light-resistant container, out of reach of children. The medication is packaged in a container with 90 capsules and the prescribing information can be found in the package insert. The medication is manufactured by Cadia Healthcare Ltd.*

FDA Label Image

Figure (7c8a7657 5d39 4386 A12f 54222c21b724 06)

This is a description of a medication with the active ingredient diltiazem hydrochloride in 360mg dose. The medication is in the form of extended-release capsules and comes in a container with 90 capsules with a child-resistant closure. The package insert provides complete prescribing information, and the medication should be stored at 20°C to 25°C. The information also includes the manufacturing company, Cadila Healthcare Ltd, located in Ahmedabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.